Background: Comorbid personality disorders may predispose patients with mood disorders to suicide attempts (SAs), but factors mediating this effect are not well known. Methods: Altogether 597 patients from three prospective cohort studies (Vantaa Depression Study, Jorvi Bipolar Study, and Vantaa Primary Care Depression Study) were interviewed at baseline, at 18 months, and in VDS and PC-VDS at 5 years. Personality disorders (PDs) at baseline, number of previous SAs, lifecharted time spent in major depressive episodes (MDEs), and precise timing of SAs during follow-up were determined and investigated. Results: Overall, 219 (36.7%) patients had a total of 718 lifetime SAs; 88 (14.7%) patients had 242 SAs during the prospective follow-up. Having any PD diagnosis increased the SA rate, both lifetime and prospectively evaluated, by 90% and 102%, respectively. All PD clusters increased the rate of new SAs, although cluster C PDs more than the others. After adjusting for time spent in MDEs, only cluster C further increased the SA rate (by 52%). Mediation analyses of PD effects on prospectively ascertained SAs indicated significant mediated effects through time at risk in MDEs, but also some direct effects. Limitations: Findings generalizable only to patients with mood disorders. Conclusions: Among mood disorder patients, comorbid PDs increase the risk of SAs to approximately two-fold. The excess risk is mostly due to patients with comorbid PDs spending more time in depressive episodes than those without. Consequently, risk appears highest for PDs that most predispose to chronicity and recurrences. However, also direct risk-modifying effects of PDs exist.
Introduction
Mood and personality disorders carry a significant risk of suicide. Between one-half and two-thirds of all suicides occur in patients with mood disorders (Cavanagh et al., 2003) , with lifetime risk of suicide in mood disorders in the 5-6% range, the risk being somewhat higher in bipolar disorder (BD) than in major depressive disorder (MDD) (Nordentoft et al., 2011) . Moreover, comorbid psychiatric disorders increase suicide risk (Nordentoft et al., 2011) . Of individuals who die by suicide, 30-40% of have at least one personality disorder (PD) (Foster et al., 1997; Henriksson et al., 1993) and nearly all of them have also comorbid depressive or substance use disorders, or both (Cheng et al., 1997; Henriksson et al., 1993) . Thus, individuals with co-occurring mood and personality disorders comprise the vast majority of all suicides (Foster et al., 1997) . Knowing the risk factors for suicide is necessary for rational preventive decisions. However, given suicide's low base rate, much risk factor research has focused on suicide attempts (SAs) as a proxy for suicide. The risk factors for SAs and suicide are mainly similar, although completers are more often males, have more psychotic symptoms, and use more lethal methods (Hawton et al., 2013; Isometsa, 2014 
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After informed consent DSM-IV (SCID-I/P and SCID-II) Inclusion criteria DSM-IV type I or II with a new depressive, manic, hypomanic, mixed, or depressive mixed episode of BD and PD (for reviews, see (Beghi et al., 2013; Hawton et al., 2013; Isometsa, 2014) ). Multiple interacting risk (e.g. above mentioned) and protective (e.g. meaningful and important relationships) factors influence suicidal behavior (Mann et al., 1999) . However, in prospective studies (Holma et al., 2010 (Holma et al., , 2014 Riihimaki et al., 2014a; Valtonen et al., 2008) we have shown that a major determinant, with a consistently high population-attributable fraction, is the time spent in high-risk illness phases. Compared with euthymia, the incidence of SAs during major depressive phases is 25-fold and during mixed illness episodes in BD 65-fold (Holma et al., 2014) . Among patients with mood disorders, suicidal acts in the absence of an illness episode are rare (Holma et al., 2010 (Holma et al., , 2014 Riihimaki et al., 2014a; Valtonen et al., 2008) . Both comorbid DSM-IV cluster B (Skodol et al., 2011) and C (Oleski et al., 2012) PDs have been shown to increase time that an individual spends in major depressive episodes (MDEs). The relationship between mood disorder and comorbid PDs and SAs has been investigated in longitudinal epidemiological (Bolton et al., 2010; Oleski et al., 2012) and clinical (Galfalvy et al., 2006; Oquendo et al., 2007; Stringer et al., 2013; Undurraga et al., 2012) studies among mood disorder patients and in longitudinal clinical studies among PD patients (Soloff and Chiappetta, 2012; Yen et al., 2003) . In these studies, cluster B PDs, especially borderline PD, have been established as a risk factor for SAs, whereas cluster A and C PDs have received less attention. The most consistent predictors for a future SA have been borderline PD comorbid with MDD (Bolton et al., 2010; Soloff and Chiappetta, 2012; Soloff and Fabio, 2008; Yen et al., 2003) , BD with current MDE (Galfalvy et al., 2006) , and both MDD and BD with current MDE (Oquendo et al., 2007) or dysthymia (Stringer et al., 2013) . Also baseline cluster C (Oleski et al., 2012) , dependent (Bolton et al., 2010) , avoidant (Bolton et al., 2010) , paranoid (Bolton et al., 2010) , schizoid (Bolton et al., 2010) , schizotypal (Bolton et al., 2010) , or any (Bolton et al., 2010; Undurraga et al., 2012 ) PD comorbid with MDD or MDE in BD patients has been associated with higher rates of SAs at follow-up. A number of other risk factors e.g. sociodemographic factors, number of depressive symptoms, other comorbid disorder, previous suicidal behavior have been controlled in the aforementioned studies, but not the proportion of time spent in MDEs during the follow-up; yet, it is a key predictor of accumulated risk for suicidal acts (Holma et al., 2010 (Holma et al., , 2014 Riihimaki et al., 2014a; Valtonen et al., 2008) .
In this prospective cohort study of mood disorder patients, we aimed to investigate the relationship between comorbid PDs and future SAs. We hypothesized that 1) baseline comorbid cluster C and borderline PDs would increase the rate of SAs indirectly by increasing time spent in MDEs. Moreover, 2) we expected that borderline PD would also (directly) modify the risk of SAs during MDEs.
Therefore, we investigated the relationship between comorbid PD and 1) lifetime (total retrospective and prospective) SAs and 2) prospectively evaluated new SAs during the follow-up. We also tested 3) whether comorbid PD acts directly on the rate of SAs or indirectly by increasing the duration of MDEs during the followup. In analyses of prospectively evaluated SAs, we 4) controlled for confounding sociodemographic and clinical risk factors. Finally, we conducted formal mediation analyses.
Methods
Patients came from three separate but comparable cohorts The pertinent ethics committee approved the research protocols. The detailed methodologies have been described elsewhere for JoBS (Mantere et al., 2004 , VDS (Holma et al., 2008; Melartin et al., 2002) , and PC-VDS (Riihimaki et al., 2014b; Vuorilehto et al., 2005 ) (see also Table 1 ).
Screening and baseline evaluation
Altogether 3555 primary care or psychiatric patients were screened for acute phase of unipolar depressive disorder (PC-VDS) or BD (JoBS) or MDD (VDS). Patients were fully informed about the study and gave written informed consent. Diagnoses were based on semistructured interviews (Table 1) . Most of the interviewers were psychiatrists or doctors specializing in psychiatry and two experienced clinical psychologists. In PC-VDS, two-thirds of the patients had MDD, and the rest had dysthymia, currently subsyndromal but lifetime MDD, or true minor depression. The final baseline cohorts included 191 DSM-IV BD I and II patients (JoBS), 269 MDD patients (VDS), and 137 unipolar depressive disorder patients (PC-VDS). Interrater agreement in diagnostic interviews was excellent (kappa 0.86-1.00) Melartin et al., 2002; Riihimaki et al., 2014b) .
Full DSM-IV axis I diagnoses (Structured Clinical Interview for DSM-IV Disorders, SCID-I/P (First et al., 2002) in JoBS and PC-VDS; Schedules for Clinical Assessment of Neuropsychiatry, SCAN (Wing et al., 1990) in VDS) and axis II diagnoses (Structured Clinical Interview for DSM-IV Personality Disorders, SCID-II for DSM-IV (First et al., 1997) in JoBS and PC-VDS; SCID-II for DSM-III-R in VDS) were made. Prevalence of comorbid psychiatric diagnoses are mentioned in Table 1 . Information was also gathered on demographic characteristics, current symptomatology using the 17-item Hamilton Depression Scale, HAM-D (Hamilton, 1960) , the 21-item Beck Depression Scale, BDI (Beck et al., 1961) , the 21-item Beck Anxiety Scale, BAI (Beck et al., 1988) , and the Young Mania Rating Scale, YMRS (Young et al., 1978) , and illness history using a retrospective life-chart.
Follow-up
After baseline assessments, patients were interviewed at 6 (JoBS and VDS) and 18 (JoBS, VDS, and PC-VDS) months and at 5 years (VDS and PC-VDS). Repeated SCID-I/P (JoBS and PC-VDS at all follow-ups, and VDS at 5 years), SCAN 2.0 (VDS at 18 months), and SCID-II interviews and all observer-and self-reported symptom scales were included at all follow-up assessments. Course of illness was documented on a prospective life-chart based on DSM-IV criteria (Holma et al., 2008; Mantere et al., 2008; Riihimaki et al., 2014b; Vuorilehto et al., 2009) . Criteria for hypomania were as in the DSM-IV, except duration of at least 2 days. Sociodemographic characteristics are presented in Table 2 .
Suicide attempts
A suicide attempt was defined as a self-injurious behavior with non-fatal outcome accompanied by evidence that the person had at least some degree of intent to die ( baseline, information about previous SAs was obtained by interviews and psychiatric records. Information regarding SAs during follow-up was based on both patient interview and psychiatric and general medical records. During follow-up we assessed episodes of depression and SAs independently by questioning the patients first about their life events and mood, and then about SAs, to avoid automatically attributing the disorders to each other or the acts to the episode.
Study design
We examined whether baseline comorbid PDs predicted number of prospectively ascertained SAs at follow-up or were associated with number of lifetime (including prospective) attempts. Formal mediation tests were conducted for all three PD clusters and for specific PDs on SA risk. For further methodological details, see Supplementary materials.
Statistical methods
The statistical data analyses were conducted using R-software, 64-bit Linux version 2.15.3. Poisson regression was applied in modeling the number of SAs per month (participant-specific 'offset' for the time of exposure) as a function of independent variables (see online supplementary materials for further details). Overdispersal was present when studying lifetime attempts (dispersion test in "AER" R-package version 1.2-1), and thus, quasiPoisson models were used for this outcome (Cameron and Trivedi, 1990) . Missing data were modeled using Multiple Imputation by Chained Equations (see online supplement), and imputed results are presented along with a non-imputed sensitivity analysis (van Buuren and Groothuis-Oudshoorn, 2011). As a further sensitivity analysis, we studied whether PDs were differentially associated with having attempted suicide (status) versus the number of attempts. The status outcome of having attempted suicide or not was modeled using Logistic Regression models. The possible mediating role of depressive episodes between PD and SA was studied using "mediation" R-package (version 4.4.3), with a linear regression model for time spent in MDEs, a Poisson regression model for number of SAs, and a logistic regression for attempterstatus outcome (Imai et al., 2010) . For a statistical power analysis, see the online supplement.
Results
In total, 219 (36.7%) patients had had one or more lifetime (total retrospective and prospective) SAs, whereas 88 (14.7%) patients made one or more attempts during their life-charted followup period. Total number of lifetime SAs in the whole sample was 718 (mean¼1.20; s.d. ¼2.79). Altogether 242 new attempts were observed during the follow-up period, with the average rate of new attempts being 0.018 attempts/month (s.d. ¼ 0.074).
Personality disorders in relation to suicide attempt rates
Participants with any PD diagnosis at baseline had a 90% increase in the rate of lifetime SAs, and a 102% increase in prospectively observed SAs relative to participants without PDs. Even during the high-risk state of MDE, presence of any PD increased the rate of a new SA by 39% and a cluster C disorder nearly doubled (90% increase) the SA rate. See Table 3 for results for all PD clusters, for borderline PD specifically, and, as a reference, also for previous attempt.
A post-hoc analysis of the cluster C diagnoses revealed that avoidant PD (81.5% increased rate of SAs [95% CI ¼22.0%, 168.0%]) 
Mediating role of depressive episodes
We assessed whether the time spent in MDEs during the follow-up mediated the effects of PDs on new SAs (Fig. 1) . The effects of cluster B and borderline PD on both SA rate and probability of a new SA were clearly mediated by the time spent in MDEs. Cluster C appeared to have mediated effects, with possible but non-significant direct effects on SAs as well. Cluster A's effects on SA rates were similarly mediated by the time spent in MDEs, with some non-significant indications for possible direct effects only when SAs were analyzed categorically.
Other risk factors and subgroups
We adjusted the PD-SA associations for several potential confounders and also evaluated them in relevant subgroups (Table 4) .
As expected from the mediation analysis, adjusting for the time spent in MDEs attenuated all predictive effects for the rate of new SAs, excluding the one for cluster C PD. In addition, the original findings for clusters A and B were non-significant in BD patients and were attenuated by adjusting for social support in all patients (Table 4 ). Because the lack of studies on suicidality of primary care patients has been emphasized (Hawton et al., 2013) , we also presented a subsample analysis of the small primary care sample (n ¼130). Despite low statistical power, the qualitative findings were similar to those for the total sample.
Discussion
Personality disorders have been known to increase mood disorder patients' risk of suicide attempts, but the reasons for this have remained unclear. We investigated the relationship between personality disorders (PDs) and suicide attempts (SAs) in three prospectively studied mood disorder cohorts, finding the risk of SAs to be generally two-fold among patients with a PD. A main finding was that the influence of an individual's PD on SA risk was mostly indirect, mediated by increased time spent in high-risk states, i.e. major depressive episodes (MDEs). However, PDs also had some direct risk-modifying effects on SA rate during depressive episodes; the best evidence for such influences emerged for cluster C PDs.
This study has numerous methodological strengths. To our knowledge, this is the first study evaluating whether the increased suicidal behavior among PD patients could be explained (mediated) by their greater time at risk (in depressive states) relative to other patients. Information on SAs was gathered both retrospectively and prospectively during the follow-up, with consistent findings of risk factors in both time-frames. The most important strength was availability of prospectively collected life-charts with information on illness course and timing of SAs, allowing testing of mediator hypotheses. Patients were assessed prospectively with semistructured interviews with excellent interrater reliability and both objective and subjective structured and semistructured measures. Information regarding all comorbid axis I and II disorders at baseline was also available. Besides comorbid axis II disorders, we investigated a broad range of risk and protective factors from several domains, including axis I comorbid disorders and symptoms, history of suicidal behavior, and psychosocial factors, on the risk of SAs. All cohorts employed similar methodology, allowing valid comparisons and pooling of data.
Nevertheless, some limitations also exist. The lengths of followups differed, as the five-year follow-up data from the JoBS were not yet available at the time of analysis. The data were therefore modeled in Poisson regressions using the standard offset, or length-of-exposure, term. Second, similarly to any study including a retrospective evaluation, recall bias is possible, and depression might affect recall of previous SAs. Third, although no specific scale for the assessment of SAs was used (e.g the Suicide Intent Scale, Beck et al., 1974) , the evaluation of the rate of new SAs was probably not over-or underestimated due to the thorough interviews, typically lasting 2-3 h and the life chart methodology used. Fourth, it was only possible to investigate time spent in crudely classified risk states instead of detailed temporal tracking of individual-specific risk states. Risk for attempts likely covaries significantly with levels of depression, hopelessness, and possibly anxiety, none of which were measured on a daily or moment-tomoment basis. Thus, the observed gradient between symptom states (Holma et al., 2010 (Holma et al., , 2014 Riihimaki et al., 2014a; Valtonen et al., 2008) is likely an underestimate. Fifth, sample sizes restricted the accuracy of estimates. Sixth, the study was naturalistic, and treatments for mood disorders were not controlled, although Table 4 Personality disorder-associated increases (%) in rate of new suicide attempts (SA) under further adjustments and sensitivity analyses with multiple imputation (n¼ 555).
Adjusted variable
Any PD Cluster A Cluster B Cluster C Borderline they may influence both the time ill and the risk for SAs. How often comorbid personality disorders were clinically recognized and whether treatments were focused on them remain unknown. Seventh, the SCID-II interviews were based on DSM-IV in PC-VDS and JoBS, but DSM-III-R in VDS. There are also minor differences in PD diagnostic criteria between DSM-III-R and DSM-IV. Eigth, the diagnostic criteria for borderline PD include suicidal behavior, which to the degree that past "recurrent suicidal behavior, gestures, or threats, or self-mutilating behavior" predicts future SAa could cause a tautological increase in the predictive value of borderline PD for future attempts. However, in a sensitivity analysis, whether or not the suicide item was included in the diagnosis had no influence on our findings. Ninth, we cannot exclude the possibility that some personality traits not fully captured by the DSM PD constructs, e.g. impulsive or nonimpulsive aggressive traits (Dalca et al., 2013; Keilp et al., 2006; Mann et al., 2009; McGirr et al., 2008) might have important moderating effects on risk for suicidal acts. Thus, a study of the influence of clinical PDs is not a full account of the impact of all personality traits. Finally, it is important to understand the nature of the cohorts investigated; we investigated the influence of PDs on SAs among psychiatric care patients with unipolar and bipolar major mood disorders and among primary care patients with depressive disorders. Generalizability of findings to patients with PDs without mood disorders, or to completed suicides among patients with mood disorders, not to speak of other patients, requires further confirmation. Diagnosis of any comorbid PD was associated with an approximately two-fold rate of both lifetime SAs and new (prospectively observed) SAs among mood disorder patients, in agreement with earlier studies (Bolton et al., 2010; Undurraga et al., 2012) . However, after adjustment for time spent in MDEs, all of the associations, except those with cluster C PDs, were attenuated and became non-significant. Thus, the influence of comorbid PD on the rate of new SAs is mostly mediated by the time spent in high-risk state, i.e. in MDEs. This is consistent with our previous study, where the influence of an individual's temperament and character on suicide attempt risk was mediated by the time spent in MDEs (Jylha et al., in Press) . Thus, irrespective of whether the variation in personality is conceptualized as a trait dimension or a diagnostic category, its impact is mostly mediated by an associated predisposition to spend extended periods in depressive states, which then carry a high risk for suicidal acts.
A small and rarely discussed minority of individuals with mood disorders suffer from cluster A PDs. We found that also these PDs increased the rate of prospectively evaluated new SAs, even after adjusting for age, gender, sampling cohort, and previous SAs. This is in accord with a previous study (Bolton et al., 2010) in which schizoid, paranoid, and schizotypal PDs were associated with future SA. However, our finding was non-significant in bipolar patients, and was attenuated by adjusting for the generally weaker social support among these patients, and only half of that total effect was mediated by the time spent in MDE. Nevertheless, time spent in MDEs during the follow-up mediated the effects of cluster A PDs on the rate of new SAs. Overall, increased risk of SAs among mood disorder patients with cluster A PDs is likely to be due to multiple reasons, including increased time depressed, weaker social support, and direct effects of the PD when depressed. Whether or not the cognitive distortions typical for these patients influence the risk remains unknown.
Cluster B and borderline PDs increased the rate of lifetime and new SAs. This was expected and fully in line with earlier studies (Bolton et al., 2010; Soloff and Chiappetta, 2012; Soloff and Fabio, 2008; Yen et al., 2003) . Of separate DSM-IV borderline PD criteria only identity disturbance predicted new SAs after adjusting for age, sex, having had a previous suicide attempt, and number of previous attempts. This finding is in contrast to an earlier study (Yen et al., 2004) , in which affective instability most strongly associated with suicidal behavior. In our analysis, the effect of Cluster B and borderline PD on both the rate and probability of new SAs was clearly found to be mediated by the time spent in MDEs. While this is concordant with findings of the US NESARC study (Skodol et al., 2011) , we nevertheless also expected a major riskmodifying effect when depressed. Three factors may have influenced our findings. First, while we deliberately included mood disorder patients with all types of comorbid disorders in the cohorts, patients with substance-induced mood episodes were not included. Thus, some of the borderline PD patients most at risk for suicidal behavior were possibly excluded, and those included were likely less substance-abusing than borderline patients at large. Second, the mean age of about 40 years in the mood disorder cohorts differs from most cohort studies of borderline PD, which mostly involve young adults. Therefore, the clinical profile of our patients was likely also different, reflecting later phases in the course of PDs. Third, in the absence of specialized services for patients with borderline PD at the time of data collection, highly impulsive patients may have visited psychiatric settings only briefly at times of crisis and might thus have been less likely to be included in the two psychiatric cohorts. Therefore, while our findings provide evidence for the risk-increasing role of borderline PD because of more time spent depressed, they do not negate the findings of studies determining other aspects of borderline psychopathology to be important.
Cluster C PDs are generally not perceived to markedly contribute to the risk of suicidal acts. However, we found them to play an important role among mood disorder patients due to their strong influence on chronicity and recurrences of unipolar and bipolar mood disorders (Holma et al., 2008; Pallaskorpi et al., 2015) , and the associated increase in the rate of lifetime and prospectively evaluated new SAs. This impact of comorbid cluster C PDs (that is not found with comorbid cluster B PDs) on the increased risk of SAs might be due to other common underlying risk factors affecting on chronicity and recurrences of mood disorders e.g. personality traits (Rosenström et al., 2014) or low level of social support (Leskelä et al., 2004) . In line with our finding, new SAs were also found to be associated with cluster C PDs in a previous study (Oleski et al., 2012) . Moreover, even during the high-risk period of MDE, cluster C PDs nearly doubled the SA rate. It is possible that the influence on risk of suicidal acts varies depending on the specific PD. In post-hoc analyses, we found that during the total follow-up cluster C, avoidant, and dependent PDs, but not obsessive-compulsive PD, increased the rate of new SAs by 165%. Moreover, the number of symptoms for avoidant PD had a rough dose-response relationship with the rate of new SAs. About half of the effect of cluster C PDs on the rate of new SAs, and about 2/3 of the effect on the probability of making at least one SA, was mediated by the time spent in MDEs. Thus, cluster C PDs seem to have an effect on SAs both by increasing time at risk and by increasing risk when depressed.
In conclusion, among mood disorder patients, comorbid PDs increase the risk of SAs by approximately two-fold. The excess risk is mostly due to the finding that patients with comorbid PDs spend more time in depressive episodes than those without comorbid PDs. Consequently, the risk was highest for PDs that most strongly predispose to more time depressed. This putative causal pathway has important clinical implications because MDEs are treatable. However, direct risk-modifying effects of PDs are also likely to exist.
